HMA mediated downregulation of MCL-15-Aza down-regulates MCL-1 in a p53-independent manner, leading to enhanced apoptosis in AML cells when combined with ABT-737 (inhibitor of BCL-2 and BCL-xL). The gene discussed is BCL2; the disease is acute myeloid leukemia.